ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors ...Middle East

PR Newswire - News
ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
Partnership combines ARTBIO's AlphaDirect™ platform for 212Pb-based alpha radioligand therapies with 3B Pharmaceuticals' expertise in peptide radioligand therapy discovery and development ARTBIO gains exclusive global license for highly novel program close to clinical development...

Read More Details
Finally We wish PressBee provided you with enough information of ( ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors )

Also on site :



Latest News